Jeffrey J. Ansley
Shareholder
300 Crescent Court, Suite 400 Dallas, Texas 75201
- jansley@vedderprice.com
- VCard
Jeffrey J. Ansley
Shareholder
Jeffrey J. Ansley is a Shareholder in Vedder Price’s Government Investigations & White Collar Defense group focused on white collar defense, representing professionals and corporate clients in criminal and regulatory investigations and in court when the time comes.
He has long been a white collar trial lawyer with a special focus on health care fraud, securities fraud and other alleged business crimes. Mr. Ansley regularly represents individuals and companies in complex matters involving the Department of Justice (DOJ), the U.S. Department of Health and Human Services Office of Inspector General (HHS-OIG), the Health Care Fraud Prevention and Enforcement Action Team (HEAT) and Health Care Fraud Strike Force, the Securities and Exchange Commission (SEC), the Department of Defense (DOD), the Federal Bureau of Investigation (FBI) and many other government agencies.
Mr. Ansley is a Chambers USA-ranked, seasoned white collar criminal defense trial lawyer and former federal prosecutor for the Northern District of Texas. He has successfully tried numerous federal criminal cases for and against the government, including recently as lead trial counsel in a month-long jury trial that resulted in a complete defense verdict for his client in an alleged $500 million health care fraud and kickback scheme. His practice focuses exclusively on white collar criminal defense, federal trials and grand jury matters, internal investigations, and regulatory and enforcement actions by federal and state agencies. He routinely handles cases involving the False Claims Act (FCA) and parallel criminal investigations, the Anti-Kickback Statute (AKS), the Stark Law, health care fraud, the Foreign Corrupt Practices Act (FCPA), whistleblower claims, securities and other financial fraud, accounting irregularities, insider trading, official bribery and public corruption, government contractor fraud, import and export controls, immigration, tax fraud, antitrust, bank fraud, money laundering, obstruction of justice, extortion, consumer protection, and mail, wire, and honest services fraud. Mr. Ansley’s practice routinely places him between his clients and the government.
In the health care industry, he regularly defends physicians and other health care providers, practice groups, hospitals, dentists, DSOs, pharmacists and marketers in criminal and regulatory investigations, prosecutions and trials. In the securities industry, he regularly represents public companies, their officers and directors, broker-dealers, financial advisers, advisory firms, and other securities industry professionals and entities in connection with investigations and proceedings by the DOJ, SEC, Financial Industry Regulatory Authority (FINRA) and state securities regulators.
Mr. Ansley also has led numerous internal investigations into possible criminal and regulatory misconduct and counsels clients regarding compliance in these areas.
Before joining Vedder Price, Mr. Ansley served for more than eight years as an Assistant U.S. Attorney (AUSA) in the Major Fraud and Public Corruption Section of the U.S. Attorney’s Office for the Northern District of Texas, investigating and prosecuting complex federal crimes. As an AUSA, he led the inter-agency Securities Fraud Task Force, where he prosecuted and tried some of the District’s most complex securities fraud, health care fraud and major corruption cases. Notably, he was lead counsel in the investigation, prosecution and eventual seven-week trial of the International Product Investment Corporation (IPIC) Ponzi scheme, at the time the largest Ponzi scheme in the Northern District of Texas, which culminated in guilty verdicts and decades-long sentences for the architects of the fraud.
Thanks to his combined experience as a former fraud prosecutor and SEC attorney, Mr. Ansley has an insider’s knowledge of the tactics used by prosecutors and investigators, resources that he uses on behalf of his clients to combat them. This experience makes him uniquely qualified to handle not only these investigations and charges, but also the collateral regulatory, administrative and civil consequences that often accompany them.
Mr. Ansley is ranked by Chambers USA for “Litigation: White-Collar Crime & Government Investigations,” where he is described as “one of my go-to for white-collar matters” and “very, very well versed in healthcare fraud investigations and defense.” He has been selected by his peers for inclusion in The Best Lawyers in America® since 2018, was named a “Litigation Star” in the Benchmark Litigation 2020 guide, and has been selected by his peers for inclusion in Thompson Reuters Super Lawyers since 2010. He has been consistently recognized by Texas Monthly and D Magazine as a top practitioner and for the strength of his white collar defense practice. He is a frequent speaker, author and commentator.
Jeffrey J. Ansley
Shareholder
Education
- SMU Dedman School of Law, J.D., 1994
- Texas A&M University, B.A., 1991, cum laude
Jeffrey J. Ansley
Shareholder
Bar Admissions
- Texas, 1994
Court Admissions
- U.S. District Court, Eastern District of Texas, 2008
- U.S. District Court, Northern District of Texas, 1994
- U.S. District Court, Southern District of Texas, 2008
- U.S. District Court, Western District of Texas, 2008
- U.S. District Court, Southern District of Mississippi, 2020
- U.S. Court of Appeals, Fifth Circuit, 2009
Affiliations
- Fellow, Texas Bar Foundation
- Member, Federal Bar Association
- Member, American Bar Association, White Collar Section
- Member, Dallas Bar Association, Criminal Law and Securities Law Sections
- Member, American Health Lawyers Association
Jeffrey J. Ansley
Shareholder
-
Publications
-
February 16, 2023 | Article
-
July 18, 2022 | Publication
-
May 27, 2022 | Newsletter/Bulletin
-
September 2, 2022 | PublicationWill PPP Fraud Turn into the Next Wave of 'Liar's Loans'? Accounting Today
-
June, 2020 | PublicationHow Federal and State Workers May Impact Care in Texas D Magazine
-
July, 2018 | PublicationThe Criminal Regulatory Framework Health Care Compliance Association (HCCA) Compliance Today
-
August, 2015 | PublicationThe Anatomy of an SEC Investigation eb5 Investors, Vol. 2, Issue No. 3
-
March, 2014 | PublicationThe Ends Do Not Justify the Means: Pre-Trial Asset Freezes Increasingly Paralyze the Defense The Texas Lawbook
-
May, 2013 | PublicationFacebook, You and the Government: The SEC Is Following Your Tweets The Texas Lawbook
-
December, 2011 | PublicationWhere Did My Privilege Go? Congress and Its Discretion to Ignore the Attorney-Client Privilege Criminal Law Bulletin
-
October, 2011 | PublicationRisks and Mistakes Come with the Territory: The Difficult Task of the SEC The Texas Lawbook
Jeffrey J. Ansley
Shareholder
-
News
-
August 17, 2023 | Press Release
-
June 1, 2023 | Press Release
-
April 27, 2023 | Press Release
-
August 18, 2022 | Press Release
-
June 1, 2022 | Press Release
-
February 10, 2022 | Press Release
-
Jeffrey J. Ansley
Shareholder
Experience
*Includes in some cases Mr. Ansley’s previous experience
- Successfully defended pharmacist accused of conspiracy to commit health care fraud and violation of the Anti-Kickback Statute in multi-week federal jury trial
- Successfully defended trader against insider trading securities fraud charges in federal jury trial
- Successfully tried multiple federal jury trials involving charges of securities fraud, health care fraud, public corruption, bank fraud, wire and mail fraud, tax fraud, money laundering and conspiracy
- Successfully secured pretrial diversion agreements on behalf of health care, securities, and other industry professionals accused of health care fraud and violations of the Anti-Kickback Statutes, Computer Fraud and Abuse Act, Economic Espionage Act, and similar complex federal crimes
- Routinely defend physicians, dentists, pharmacists, marketers, lab owners and related individuals in health care fraud investigations and prosecutions
- Routinely defend corporate officers, directors and other management in securities fraud investigations and prosecutions
- Successfully defended healthcare staffing company and its senior personnel in federal False Claims Act investigation and preempted DOJ intervention
- Successfully defended recipient company of federal educational grant funds in federal False Claims Act investigation and preempted DOJ intervention
- Conducted numerous internal investigations involving allegations of securities fraud, fund misappropriation, accounting fraud or other improper accounting practices, health care fraud, and violations of the False Claims Act, Anti-Kickback Statute and Stark Law, among other complex statutes and regulations
- Defended physician charged with health care fraud and conspiracy involving a hospice facility
- Defended corporate officer charged with securities fraud, wire fraud and conspiracy
- Successfully defended dentist and DSO owner in federal Anti-Kickback Statute case
- Conducted internal investigation on behalf of corporation regarding allegations of embezzlement and misappropriation of funds by a senior executive
- Successfully defended bank against charges by the FDIC of improper lending practices
- Represented health care executive in a federal sentencing in connection with money laundering, health care fraud and corruption charges
- Represented and obtained below-Guidelines sentences for physicians, securities professionals, securities traders and others against federal charges
- Successfully defended and secured closure of investigations by the DOJ and SEC relating to suspected insider trading
- Defended senior executive in federal jury trial charged with conspiracy and securities fraud in connection with complex real estate offerings